Drugs / Sarecycline
Sarecycline
also known as
P-00562 · P-005672 · PO-05672 · Sareciclina · SARECYCLINE HYDROCHLORIDE · Seysara · WC-3035
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | SEYSARA | — | 2018-10-01 | fda.gov ↗ |
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 33 trials | ||||||
| Phase 3 | NCT02413346 | Mar 2015 → Aug 2016 | acne | Almirall, S.A. | Completed | No outcome recorded |
| Phase 3 | NCT02320149 | Dec 2014 → Feb 2017 | acne | Almirall, S.A. | Completed | No outcome recorded |
| Phase 3 | NCT02322866 | Dec 2014 → Jan 2017 | acne | Almirall, S.A. | Completed | No outcome recorded |
| Phase 43 trials | ||||||
| Phase 4 | NCT07544251 | Apr 2026 → Apr 2027 expected | acne | Integrative Skin Science and Research | Recruiting | No outcome recorded |
| Phase 4 | NCT06461299 | Jul 2023 → Mar 2024 | acneiform dermatitis | The Dermatology Institute of Boston | Completed | No outcome recorded |
| Phase 4 | NCT04555525 | Apr 2019 → Sep 2020 | rosacea | Derm Research, PLLC | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05836753 Comparator | May → Nov 2023 | ischemic stroke | Beijing Tiantan Hospital | Unknown | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sarecycline | “Study to Evaluate the Efficacy, Safety, and Tolerability of Sarecycline for Treating Periorificial Dermatitis” NCT06461299 ↗ |
| Known as | P-00562 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2364632 ↗ |
| Known as | P-005672 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2364632 ↗ |
| Known as | PO-05672 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2364632 ↗ |
| Known as | Sareciclina | ChEMBL registry synonym — accepted as the source's own label CHEMBL2364632 ↗ |
| Known as | SARECYCLINE HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL2364632 ↗ |
| Known as | Seysara | ChEMBL registry synonym — accepted as the source's own label CHEMBL2364632 ↗ |
| Known as | WC-3035 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2364632 ↗ |
| Modality | Small molecule | — CHEMBL2364632 ↗ |
| Route | Oral | “taken orally” NCT02320149 ↗ |